UroGen Pharma Ltd.
- URGN
- NASDAQ
- Biotechnology
- Urologic Oncology
- RTGel Drug Delivery Technology
$33.74
Today −2.37%Quote Oct 19, 2026, 02:05 PM UTC
−21.37%over the last month
Max drawdown −21.4%From 1-month high −21.4%3 months −16.0%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$1.65B
Quote Oct 19
Next earnings
Nov 5
Expected, not confirmed
Analyst target
$56.60
+67.8% from here
Floor
$32.83
2.7% below price
Where the price sits
16 analysts
Analyst range, low to high
$44.00$75.00
- Price $33.74
- Resistance $36.35–$36.71
- Consensus $56.60
Analysts' average target sits about 68% higher. Their range is wide.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about URGNPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
No revenue split by segment on file.
Industry
Biotechnology
Employees
300
Founded
2004